A 72-year-old man with recurrent PAD claudication despite medical therapy undergoes endovascular stenting. He asks about antithrombotic strategy. Whic...

Question

A 72-year-old man with recurrent PAD claudication despite medical therapy undergoes endovascular stenting. He asks about antithrombotic strategy. Which is most consistent with the PAD guideline to reduce limb and CV events?

Accepted Answer

Rivaroxaban 2.5 mg twice daily plus aspirin lifelong if bleeding risk acceptable

Answer

Aspirin alone lifelong

Answer

Clopidogrel alone lifelong

Answer

Dual antiplatelet therapy indefinitely

Answer

Full-dose rivaroxaban 20 mg daily alone

us-abim MCQ (SBA): Peripheral Artery Disease

A 72-year-old man with recurrent PAD claudication despite medical therapy undergoes endovascular stenting. He asks about antithrombotic strategy. Which is most consistent with the PAD guideline to reduce limb and CV events?